The Centers for Medicare and Medicaid Services has unveiled final guidance explaining how its negotiations with manufacturers over drug prices for Medicare patients will proceed. Congress last year authorized price bargaining on a limited number of medicines. Host Kelly Hooper talks with Robert King about how it will work.

Learn more about your ad choices. Visit megaphone.fm/adchoices